Elsevier, The Lancet Child and Adolescent Health, Volume 6, June 2022
Background: There are 15·4 million children who are HIV-exposed and uninfected worldwide. Early child development crucially influences later academic and socioeconomic factors. However, the neurodevelopmental outcomes of HIV-exposed uninfected (HEU) children in the era of maternal antiretroviral therapy (ART) remain unclear. We aimed to examine the effects of in-utero exposure to HIV and ART on child neurodevelopment.
Elsevier,
Clinical Breast Cancer, Volume 22, June 2022
This study explores the current status and problems of breast cancer treatment with schizophrenia, including advanced stage diagnosis. It finds that patients with schizophrenia with reduced ADL are less likely to receive chemotherapy or recommended cancer treatment, and as such it is highly recommended that they breast cancer screening so that they can be diagnosed early and treated adequately.
Elsevier,
IBRO Neuroscience Reports, Volume 12, June 2022
This review attempts to shed more light on the prevalence of depression in Sub-Saharan Africa (SSA), its pathophysiology, risk factors, diagnosis and the experimental models available to study depression within the sub-region. It also evaluates the contribution of the sub-region to the global research output of depression as well as bottlenecks associated with full exploitation of the sub region’s resources to manage the disorder.
Elsevier,
IBRO Neuroscience Reports, Volume 12, June 2022
Financial constraints usually hinder students, especially those in low-middle income countries (LMICs), from seeking mental health interventions. Hence, it is necessary to identify effective, affordable and sustainable counter-stress measures for college students in the LMICs context. This study examines the sustained effects of mindfulness practice on the psychological outcomes and brain activity of students.